# FDA Inspection 772283 - Vitalant - March 14, 2012

Source: https://www.keypedia.com/records/fda_inspections/vitalant/e19c8a3e-a85e-488e-911a-70a3f62dc86b
Source feed: FDA_Inspections

> FDA Inspection 772283 for Vitalant on March 14, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 772283
- Company Name: Vitalant
- Inspection Date: 2012-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1159223 - 2021-12-03](https://www.keypedia.com/records/fda_inspections/vitalant/8eb5f687-570d-46a6-ba49-bdfd9256ced6)
- [FDA Inspection 1159223 - 2021-12-03](https://www.keypedia.com/records/fda_inspections/vitalant/20f809c2-14a1-4c81-9732-73c23ea888fa)
- [FDA Inspection 1057131 - 2018-06-13](https://www.keypedia.com/records/fda_inspections/vitalant/f0d2b148-3f48-4f67-a325-4ab54db07330)
- [FDA Inspection 973302 - 2016-06-02](https://www.keypedia.com/records/fda_inspections/vitalant/83e94c29-2907-4ea9-8fda-71ace2424635)
- [FDA Inspection 866040 - 2014-02-14](https://www.keypedia.com/records/fda_inspections/vitalant/cb507b5e-8c22-4e7a-82b0-14b3a97e05b9)

Company: https://www.keypedia.com/companies/vitalant/64d2e03b-56b5-4241-a5a2-1dc5679565ea

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d